High Plasma Levels of the Soluble Form of CD30 Activation Molecule Reflect Disease Activity in Patients with Wegener's Granulomatosis (Q73498924)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217665 AND SRC:MED&resulttype=core&format=json

4 November 2019

title

High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217665 AND SRC:MED&resulttype=core&format=json

4 November 2019

High Plasma Levels of the Soluble Form of CD30 Activation Molecule Reflect Disease Activity in Patients with Wegener's Granulomatosis (English)

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)00049-1

13 September 2024

5

H. Lemke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9217665

13 September 2024

author name string

G. Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9217665

13 September 2024

H. Hansen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9217665

13 September 2024

E. Tatsis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9217665

13 September 2024

E. Csernok

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9217665

13 September 2024

W. L. Gross

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9217665

13 September 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9217665

13 September 2024

publication date

1 June 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217665 AND SRC:MED&resulttype=core&format=json

full work available at URL

4 November 2019

https://api.elsevier.com/content/article/PII:S0002934397000491?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)00049-1

https://api.elsevier.com/content/article/PII:S0002934397000491?httpAccept=text/plain

13 September 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)00049-1

American Journal of Medicine

13 September 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217665 AND SRC:MED&resulttype=core&format=json

4 November 2019

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217665 AND SRC:MED&resulttype=core&format=json

4 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217665 AND SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

517-523

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217665 AND SRC:MED&resulttype=core&format=json

A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

Biology of human TH1 and TH2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

A zinc metalloproteinase is responsible for the release of CD30 on human tumor cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30 T cell involvement in the inflamed joints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

Serum levels of soluble CD30 in chronic hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

The role of cellular immunity in systemic vasculitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

Cell-mediated autoimmunity in patients with Wegener's granulomatosis (WG)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

The soluble interleukin-2 receptor in rheumatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

The IL-2/IL-2 receptor system: a target for rational immune intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(97)50049-1

7 January 2021

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217665 AND SRC:MED&resulttype=core&format=json

4 November 2019

1 reference